{"id":"https://openalex.org/W2045843002","doi":"https://doi.org/10.1177/0269881107077718","title":"(\u00b1) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics","display_name":"(\u00b1) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics","alternate_titles":[],"publication_year":2007,"publication_date":"2007-05-01","ids":{"openalex":"https://openalex.org/W2045843002","doi":"https://doi.org/10.1177/0269881107077718","mag":"2045843002","pmid":"https://pubmed.ncbi.nlm.nih.gov/17591657"},"language":"en","primary_location":{"id":"doi:10.1177/0269881107077718","doi":"https://doi.org/10.1177/0269881107077718","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107077718","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2045843002"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075051156","display_name":"Jackie Cilia","orcid":"https://orcid.org/0000-0003-1750-0629","observed_orcids":["https://orcid.org/0000-0003-1750-0629"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jackie Cilia","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline, Harlow, UK,","Psychiatry CEDD, GlaxoSmithKline, Third Avenue, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline, Harlow, UK,","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline, Third Avenue, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052205712","display_name":"Paula D. Hatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paula Hatcher","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067611395","display_name":"Charlie Reavill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlie Reavill","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053289107","display_name":"Declan N.C. Jones","orcid":"https://orcid.org/0000-0001-6988-3604","observed_orcids":["https://orcid.org/0000-0001-6988-3604"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Declan N. C. Jones","raw_affiliation_strings":["Psychiatry CEDD, GlaxoSmithKline, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry CEDD, GlaxoSmithKline, Harlow, UK","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5075051156"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.0906,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.74816364,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"21","issue":"3","first_page":"302","last_page":"311"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.8500000238418579},{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.7670000195503235},{"id":"https://openalex.org/keywords/acoustic-startle-response","display_name":"acoustic startle response","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sensorimotor-gating","display_name":"sensorimotor gating","score":0.9580000042915344},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.781000018119812},{"id":"https://openalex.org/keywords/schizophrenia-model","display_name":"schizophrenia model","score":0.7559999823570251},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8069999814033508},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9940000176429749},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":1.0},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.7940000295639038},{"id":"https://openalex.org/keywords/glutamatergic-system","display_name":"glutamatergic system","score":0.8600000143051147},{"id":"https://openalex.org/keywords/translational-model","display_name":"translational model","score":0.8700000047683716}],"concepts":[{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.9653068780899048},{"id":"https://openalex.org/C2777845764","wikidata":"https://www.wikidata.org/wiki/Q430986","display_name":"Startle response","level":2,"score":0.7612783908843994},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.7067670822143555},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.6074889898300171},{"id":"https://openalex.org/C137431309","wikidata":"https://www.wikidata.org/wiki/Q1383576","display_name":"Moro reflex","level":3,"score":0.5633636713027954},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5562769174575806},{"id":"https://openalex.org/C50610925","wikidata":"https://www.wikidata.org/wiki/Q1136816","display_name":"Habituation","level":2,"score":0.5488555431365967},{"id":"https://openalex.org/C2909172351","wikidata":"https://www.wikidata.org/wiki/Q430986","display_name":"Startle reaction","level":3,"score":0.509849488735199},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4577457308769226},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.4479316771030426},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4292644262313843},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.4239165484905243},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3899766206741333},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3484487533569336},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34372371435165405},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.30345863103866577},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2946528196334839},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.23466965556144714},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.14304432272911072},{"id":"https://openalex.org/C83974742","wikidata":"https://www.wikidata.org/wiki/Q179405","display_name":"Reflex","level":2,"score":0.0660656988620758},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06243446469306946}],"mesh":[{"descriptor_ui":"D000077213","descriptor_name":"Lamotrigine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013216","descriptor_name":"Reflex, Startle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/0269881107077718","doi":"https://doi.org/10.1177/0269881107077718","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107077718","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:17591657","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17591657","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.851.856","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.851.856","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jop.sagepub.com/content/21/3/302.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W35011636","https://openalex.org/W111137952","https://openalex.org/W129593420","https://openalex.org/W160360038","https://openalex.org/W1964888279","https://openalex.org/W1968840456","https://openalex.org/W1972253384","https://openalex.org/W1973409122","https://openalex.org/W1974154075","https://openalex.org/W1980967004","https://openalex.org/W1987285132","https://openalex.org/W1990414759","https://openalex.org/W1991964519","https://openalex.org/W1998141074","https://openalex.org/W2005756201","https://openalex.org/W2007378394","https://openalex.org/W2008746956","https://openalex.org/W2011182878","https://openalex.org/W2011662373","https://openalex.org/W2018221542","https://openalex.org/W2020140782","https://openalex.org/W2024217117","https://openalex.org/W2028541643","https://openalex.org/W2028884770","https://openalex.org/W2030247720","https://openalex.org/W2031079134","https://openalex.org/W2039434032","https://openalex.org/W2039572620","https://openalex.org/W2042676846","https://openalex.org/W2045216666","https://openalex.org/W2047719352","https://openalex.org/W2048287572","https://openalex.org/W2049783116","https://openalex.org/W2052322775","https://openalex.org/W2052923849","https://openalex.org/W2058984805","https://openalex.org/W2084216816","https://openalex.org/W2084537640","https://openalex.org/W2086593869","https://openalex.org/W2089751548","https://openalex.org/W2095213614","https://openalex.org/W2097759310","https://openalex.org/W2101896923","https://openalex.org/W2116837408","https://openalex.org/W2122995608","https://openalex.org/W2127702112","https://openalex.org/W2155207556","https://openalex.org/W2165378197","https://openalex.org/W2167116111","https://openalex.org/W2208270236","https://openalex.org/W2329891286","https://openalex.org/W4241804791","https://openalex.org/W4250304621","https://openalex.org/W4407034851"],"related_works":["https://openalex.org/W2116837408","https://openalex.org/W2012786085","https://openalex.org/W1992625143","https://openalex.org/W2005756201","https://openalex.org/W2096824787","https://openalex.org/W2006900274","https://openalex.org/W2463138704","https://openalex.org/W1973409122","https://openalex.org/W1989054848"],"abstract_inverted_index":{"Prepulse":[0],"inhibition":[1],"(PPI)":[2],"is":[3,20,28,36,244],"the":[4,7,24,91,101,114,140,145],"reduction":[5],"in":[6,38,57,62,74,108,242,257],"startle":[8,25,152,162],"response":[9],"caused":[10],"by":[11,68,176,184,223],"a":[12,45,78,251],"low":[13],"intensity":[14],"non-startling":[15],"stimulus":[16,26],"(the":[17],"prepulse)":[18],"which":[19,64],"presented":[21],"shortly":[22],"before":[23],"and":[27,59,96,149,164,170,247],"an":[29],"operational":[30],"measure":[31],"of":[32,81,85,93,119,142],"sensorimotor":[33],"gating.":[34],"PPI":[35,60,72,106,115,143,166,173,240],"impaired":[37],"psychiatric":[39],"disorders":[40],"such":[41],"as":[42],"schizophrenia.":[43,82,258],"Ketamine,":[44],"non-competitive":[46],"N-methyl-D-aspartate":[47],"antagonist":[48],"has":[49],"been":[50],"shown":[51],"to":[52,89,99,113,136],"induce":[53],"schizophrenia-like":[54],"behavioural":[55],"changes":[56],"humans":[58],"deficits":[61,73,107,167,174,241],"rats,":[63],"can":[65],"be":[66],"reversed":[67],"antipsychotics.":[69],"Thus,":[70],"ketamine-induced":[71,105,239],"rats":[75,243],"may":[76],"provide":[77],"translational":[79,252],"model":[80,253],"The":[83],"aim":[84],"this":[86],"study":[87],"was":[88],"investigate":[90],"effects":[92],"antipsychotic":[94],"drugs":[95,97],"known":[98],"alter":[100],"glutamate":[102],"system":[103],"upon":[104],"rats.":[109],"Rats":[110],"were":[111,134,181],"habituated":[112],"procedure":[116],"[randomized":[117],"trials":[118],"either":[120],"pulse":[121,129],"alone":[122],"(110":[123],"dB/50":[124],"ms)":[125],"or":[126,213],"prepulse":[127],"+":[128],"(80":[130],"dB/10":[131],"ms)].":[132],"Animals":[133],"assigned":[135],"pre-treatments":[137],"based":[138],"on":[139,144],"level":[141],"last":[146],"habituation":[147],"test":[148,237],"balanced":[150],"across":[151],"chambers.":[153],"Ketamine":[154],"(1-10":[155],"mg/kg":[156,180,187,194,201,208,216,226],"s.c;":[157],"15":[158],"min":[159,190,197,204,211,229],"ptt)":[160,220],"increased":[161],"amplitude":[163],"induced":[165,175],"at":[168,178],"6":[169,179],"10":[171],"mg/kg.":[172],"ketamine":[177],"not":[182,249],"attenuated":[183],"clozapine":[185],"(2.5-10":[186],"s.c.;":[188],"60":[189,196,203,210],"ptt),":[191,198,205,212],"risperidone":[192],"(0.1-1":[193,200],"i.p.;":[195,202,227],"haloperidol":[199],"lamotrigine":[206],"(3-30":[207],"p.o.;":[209,217],"SB-271046-A":[214],"(5-20":[215],"2":[218],"hour":[219],"nor":[221],"potentiated":[222],"2-methyl-6-(phenylethynyl)-pyridine":[224],"(3-10":[225],"30":[228],"ptt).":[230],"These":[231],"results":[232],"suggest":[233],"that":[234],"under":[235],"these":[236],"conditions":[238],"relatively":[245],"insensitive":[246],"does":[248],"represent":[250],"for":[254],"drug":[255],"discovery":[256]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2045843002","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
